# Lenoss Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lenoss-medical

- Industry: Medical Devices & Equipment
- Headquarters: Providence, US
- Website: www.lenoss.com
- Total disclosed funding: $4M
- Latest round: Series A (May 9, 2024)
- Investors on record: 6

## About

Based in Rhode Island, US, founded in 2016, and is led by President and Chief Executive Officer Dom Messerli, Lenoss Medical, LLC operates as a developer of medical devices and equipment with biologic cementless technology for stabilizing damaged vertebrae. In March 2026, Lenoss Medical, Inc. raised USD 6 million in venture funding from Xcellerant Ventures, RightHill Ventures, Highpoint Ventures, Beacon Angels, Magpie MedTech Ventures, and Arizona Venture Development Corporation. 

Lenoss Medical, LLC developed the OsteoPearl VBA System, which is a spinal implant technology for stabilizing fractures but also provides a clinically support. The company offers medical solutions for improving bone mass and strengthening bones. In addition, the firm provides support and treatment for a variety of diseases such as severe back pain, immobility, deformity, increased health complications, decreased life expectancy, loss of self-esteem, distorted body image, and depression. 

The company plans to utilize the March 2026 funding to expand commercially, hire sales leaders, boost clinical data efforts, and grow operations and marketing.

## Funding rounds

- Series A, May 9, 2024, $4M — Vodia Ventures, Highpoint Ventures, RightHill Ventures, Xcellerant Ventures, Cherrystone Angel Group, Rouge International and Rouge Ventures

## Investors

- Vodia Ventures (https://capitalatlas.ai/funds/vodia-ventures) — Series A
- Highpoint Ventures (https://capitalatlas.ai/funds/highpoint-ventures) — Series A
- RightHill Ventures (https://capitalatlas.ai/funds/righthill-ventures) — Series A
- Xcellerant Ventures (https://capitalatlas.ai/funds/xcellerant-ventures) — Series A
- Cherrystone Angel Group (https://capitalatlas.ai/funds/cherrystone-angel-group) — Series A
- Rouge International and Rouge Ventures — Series A